Testicular cancer is one of the most common malignant tumors in the male genitourinary system, particularly affecting young men aged 15 to 40. Most patients only seek medical attention after noticing a scrotal mass. If treated promptly, the prognosis is relatively good; however, neglect or delayed intervention may lead to lymph node or distant organ metastasis, significantly impacting fertility and quality of life. Modern medical options are abundant, including surgery, chemotherapy, radiotherapy, and cell therapy, providing diverse options for patients at different stages.
Immune reconstruction cell therapy plays an important role in the treatment of testicular cancer, particularly in patients who relapse or metastasize after traditional therapies. By repairing and activating the patient’s own immune system—specifically T cells, NK cells, and others—it enables recognition and clearance of residual tumor cells, reduces recurrence rates, and enhances immune surveillance capability.
① Enhances immune surveillance: This therapy effectively identifies minimal residual cancer cells, reducing the risk of recurrence and metastasis.
② Broad applicability: Can be used as postoperative adjuvant therapy, an alternative after chemotherapy resistance, or in combination treatment.
③ Lower side effects: Compared with radiotherapy and chemotherapy, it has fewer toxic reactions and does not affect quality of life.
④ Synergistic with traditional therapies: When combined with surgery or chemotherapy, it can enhance overall efficacy.
In actual treatment, cancer patients often experience immune dysfunction, increased infection risk, and slow recovery after undergoing surgery, radiotherapy, or chemotherapy. To help patients better sustain the treatment process, improve tolerance, and enhance quality of life, phased immune reconstruction plans should be scientifically designed according to different treatment cycles.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion, boosting the effectiveness of anti-tumor treatment.
● Mid-term plan: Reduce side effects of traditional treatments, promote physical recovery, and complete standardized treatment courses.
● Long-term plan: Improve overall immunity through immune cell reconstruction, gut immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby enhancing quality of life and prolonging survival.
1. Surgery as the fundamental method
Radical orchiectomy is the first-line treatment for testicular cancer. Surgery not only serves therapeutic purposes but also has diagnostic significance. Complete removal of the affected testis during surgery avoids rupture and dissemination, laying the foundation for subsequent treatment. If the tumor is confined to the testis, surgery alone can achieve a cure.
2. Chemotherapy as the main systemic treatment
Chemotherapy is particularly crucial in non-seminomatous cases or in patients with metastasis. Standard regimens such as BEP (cisplatin, etoposide, bleomycin) are widely used for testicular cancer and show significant efficacy. Kidney and lung function should be assessed before chemotherapy, and toxic side effects monitored during treatment.
3. Radiotherapy for specific types
Seminomas are highly sensitive to radiotherapy. In early-stage seminomas, low-dose irradiation of retroperitoneal lymph nodes after surgery helps eliminate micrometastatic lesions. However, radiotherapy is not suitable for non-seminomas, and its application depends on the pathological type.
4. Hormone suppression and fertility preservation
Some patients may experience decreased testosterone levels and impaired fertility after treatment. For young men without children, sperm cryopreservation is recommended before treatment to preserve future fertility potential. Endocrine evaluation and testosterone supplementation may also be necessary when indicated.
5. Minimally invasive treatments
In recent years, some centers have attempted minimally invasive methods such as laser ablation or cryotherapy for localized suspicious lesions. However, these remain in exploratory stages, mainly used for patients unable to undergo surgery or those with localized recurrence, serving as individualized supplementary therapy.
6. Concept of individualized comprehensive treatment
Testicular cancer treatment emphasizes multidisciplinary collaboration and personalized assessment. Treatment planning should be based on tumor type, stage, presence of metastasis, and patient fertility needs to balance efficacy and quality of life. United Life International Medical Center promotes precision diagnosis and treatment pathways, integrating traditional therapies with cell therapies to optimize treatment structure and recovery planning.
Testicular cancer has a high cure rate, provided it is detected early and treated properly. Experts at United Life International Medical Center recommend that patients follow individualized, scientific comprehensive treatment plans while focusing on immune function recovery to prolong survival and improve quality of life.